Everything below concerns research peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
| Property | Value | Notes |
|---|---|---|
| Typical storage | Minus 20 C or below | Lyophilized powder, protected from light |
| Solubility class | Freely soluble in water | Also dissolves in normal saline |
| Identity method | Mass spectrometry | Measured mass compared with calculated value |
| Purity method | Reverse-phase HPLC | Reported as area percentage of main peak |
| Common counterion | Acetate | Salt form varies by supplier and batch |
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
In addition to the PFC, there is moderate to high expression of serotonin 5-HT2A receptors in the primary visual cortex (V1), as well as expression of the serotonin 5-HT2A receptor in other visual areas, and activation of these receptors may contribute to or mediate the visual effects of serotonergic psychedelics. Serotonergic psychedelics also directly or indirectly modulate a variety of other brain areas, like the claustrum, and this may be involved in their effects as well. Psychedelics may work in part by disrupting the default mode network (DMN), a collection of interconnected brain areas which has high serotonin 5-HT2A receptor expression and is said to construct our sense of space, time, and self. The ego dissolution and altered time perception caused by psychedelics correlates with DMN desynchronization, whereas psychedelic visual imagery correlates with disruption in the visual cortex. Serotonin, as well as drugs that increase serotonin levels, like the serotonin precursor 5-hydroxytryptophan (5-HTP), serotonin reuptake inhibitors, and serotonin releasing agents, are non-hallucinogenic in humans despite increasing activation of serotonin 5-HT2A receptors. Serotonin is a hydrophilic molecule which cannot easily cross biological membranes without active transport, and the serotonin 5-HT2A receptor is usually expressed as a cell surface receptor that is readily accessible to extracellular serotonin.
== Mission personnel == Astronaut: L. Gordon Cooper, Jr. Backup Astronaut: Alan Shepard Flight Director – Red Team: Chris Kraft Flight Director – Blue Team: John Hodge Mercury Seven group: In addition to Shepard, each of the original Mercury Seven astronauts supported the orbital journey of Mercury 9 - John Glenn on a command ship near Japan, Scott Carpenter in Hawaii, Gus Grissom at a tracking station in Mexico, Wally Schirra as capsule communicator at Mercury mission control at Cape Canaveral, and Deke Slayton as an observer at the Cape. Worldwide support teams: Because MA-9 would orbit over nearly every part of the world from 32.5 degrees north to 32.5 degrees south, a total of 28 ships, 171 aircraft, and 18,000 servicemen were assigned to support the mission.
== History == Unintentional use of nickel can be traced back as far as 3500 BCE. Bronzes from what is now Syria have been found to contain as much as 2% nickel. Some ancient Chinese manuscripts suggest that "white copper" (cupronickel, known as baitong) was used there in 1700–1400 BCE. This Paktong white copper was exported to Britain as early as the 17th century, but the nickel content of this alloy was not discovered until 1822. Coins of nickel-copper alloy were minted by Bactrian kings Agathocles, Euthydemus II, and Pantaleon in the 2nd century BCE, possibly out of the Chinese cupronickel.
== External links == The Extracellular Signal-Regulated Kinases MAP Kinase Resource Archived 2021-04-15 at the Wayback Machine. Extracellular+Signal-Regulated+MAP+Kinases at the U.S. National Library of Medicine Medical Subject Headings (MeSH) MAPK1 MAPK3 Info with links in the Cell Migration Gateway Archived 2014-12-11 at the Wayback Machine
Sources: en.wikipedia.org
Lately Policy and Campaigns Director, United Kingdom Homecare Association. For services to Domiciliary Care. Andrew David Arbuckle. Trustee and Fundraiser, Royal Scottish Agricultural Benevolent Institution. For services to Farming and to the community in Fife. Sarah Elizabeth Armitage. Chair of Trustees, Embark Federation. For services to Education. Paul Robert Arnold. Deputy Chief Executive and Chief Operating Officer, Information Commissioner's Office. For services to Regulation and to Equality, Diversity and Inclusion. Keith Alan Ashcroft. Lately Area Director, Environment Agency. For services to the Environment. Simon Edward Ayers. Chief Executive Officer, TrustMark. For services to Consumer Protection. Jannella Baker. Training Officer, Berkshire Search and Rescue Dogs, Lowland Rescue. For services to Search and Rescue. David Martin James Ball. For services to the community in East Anglia. Sarah Pamela Ballantine. For Charitable Fundraising in Northern Ireland. Tajinder Kaur Banwait. Founder, Urban Apothecary London. For services to Business and to the Beauty Industry. Timothy Paul Barnes. Chair, St George's Garrison Church Trust. For services to the community in the Royal Borough of Greenwich, London. Dr. Catherine Emma Baxter. University Secretary, Harper Adams University. For services to Higher Education. Gina Beard. Lead Cancer Nurse, Hywel Dda University Health Board. For services to Cancer Nursing. Robert Duncan Beaumont. Lately Governor, Ravenscliffe High School and Sports College, Halifax.
In February 2021, a series of whistleblowers reached out to the CBS Sacramento, alleging improprieties and CLIA violations at the CAP-accredited California Department of Public Health (CPDH) Valencia Branch Laboratory, which had partnered with PerkinElmer under a $1.7 billion no-bid contract. PerkinElmer subsequently sued the whistleblowers for breach of confidentiality. CBS 13 subsequently investigated the Valencia laboratory along with CDPH, which investigated itself and found the allegations substantiated. The laboratory was found to have significant immediate jeopardy deficiencies, but was not sanctioned. The laboratory medical director had previously overseen Theranos. In response, California State Senator Scott Wilk introduced The Whistleblower Protection Act (SB 947) in February 2022, to extend the existing California Whistleblower Protection Act (CWPA) afforded to California state employees to the employees of government contractors that hold state contracts over $5 million.
== Cleavage & Deprotection == The Fmoc group is rapidly removed by base. Piperidine is usually preferred for Fmoc group removal as it forms a stable adduct with the dibenzofulvene byproduct, preventing it from reacting with the substrate.
=== Bruxism === SSRI and SNRI antidepressants may cause jaw pain/jaw spasm reversible syndrome (although it is not common). Buspirone appears to be successful in treating bruxism on SSRI/SNRI induced jaw clenching.
== Further reading == Juego, Bonn (2017). "The Philippines 2017: Duterte-led authoritarian populism and its liberal-democratic roots" (PDF). Asia Maior; the Journal of the Italian Think Tank on Asia Founded by Giorgio Borsa in 1989. XXVIII. Viella s.r.l. & Associazione Asia Maior: 129–163. ISSN 2385-2526. Archived from the original (PDF) on December 1, 2022. Retrieved December 1, 2022. "The Punisher". Eye for an Eye. (Vice) Bethesda Softworks LLC. Archived from the original on March 10, 2016. Retrieved September 14, 2016.
Sources: en.wikipedia.org
Deepfakes (a portmanteau of "deep learning" and "fake") are AI-generated media that take a person in an existing image or video and replace them with someone else's likeness using artificial neural networks. Deepfakes have garnered widespread attention and concerns for their uses in deepfake celebrity pornographic videos, revenge porn, fake news, hoaxes, health disinformation, financial fraud, and covert foreign election interference. In July 2023, the fact-checking company Logically found that the popular generative AI models Midjourney, DALL-E 2 and Stable Diffusion would produce plausible disinformation images when prompted to do so, such as images of electoral fraud in the United States and Muslim women supporting India's Bharatiya Janata Party.
The large intestine contains multiple types of bacteria, and other microorganisms that can break down molecules the human body cannot process alone, demonstrating a symbiotic relationship. These microbes are responsible for gas production at host–pathogen interface, which is released as flatulence. Intestinal bacteria can also participate in biosynthesis reactions. For example, certain strains in the large intestine produce vitamin B12; an essential compound in humans for things like DNA synthesis and red blood cell production. However, the primary function of the large intestine is water absorption from digested material (regulated by the hypothalamus) and the reabsorption of sodium and nutrients. Beneficial intestinal bacteria compete with potentially harmful bacteria for space and nutrients, as the intestinal tract has limited resources. A ratio of 80–85% beneficial to 15–20% potentially harmful bacteria is proposed for maintaining homeostasis. An imbalanced ratio results in dysbiosis.
No antagonism of norepinephrine was produced by concentrations of l-synephrine up to 10−6 M. In the rabbit saphenous assay, the pD2 of l-synephrine was 4.36 (potency relative to norepinephrine ≃ 1/1700), and that of d-synephrine was < 3.00; in comparison, l-phenylephrine had pD2 = 5.45 (potency relative to norepinephrine ≃ 1/140). No antagonism of norepinephrine was produced by concentrations of l-synephrine up to 10−5 M. A study of the effects of synephrine (stereochemistry unspecified) on strips of guinea pig aorta and on the field-stimulated guinea pig ileum showed that synephrine had an agonist potency of −logKa = 3.75 in the aorta assay. In comparison, epinephrine had a potency of −logKa = 5.70. There was no significant effect on the ileum at synephrine concentrations up to about 2 × 10−4 M, indicating selectivity for the α1 receptor, but relatively low potency. In binding experiments with central adrenergic receptors, using a preparation from rat cerebral cortex, l-synephrine had pIC50 = 3.35, and d-synephrine had pIC50 = 2.42 in competition against [3H]-prazosin (standard α1 ligand); against [3H]-yohimbine (standard α2 ligand), l-synephrine showed a pIC50 = 5.01, and d-synephrine showed a pIC50 = 4.17. Experiments conducted by Hibino and co-workers also showed that synephrine (stereochemistry unspecified) produced a dose-dependent constriction of isolated rat aorta strips, in the concentration range 10−5–3 × 10−6 M.
Although they occur naturally in many foods, the flavor contributions made by glutamic acid and other amino acids were only scientifically identified early in the 20th century. The substance was discovered and identified in 1866 by the German chemist Karl Heinrich Ritthausen, who treated wheat gluten (for which it was named) with sulfuric acid. In 1908, Japanese researcher Kikunae Ikeda of the Tokyo Imperial University identified brown crystals left behind after the evaporation of a large amount of kombu broth as glutamic acid. These crystals, when tasted, reproduced the novel flavor he detected in many foods, most especially in seaweed. Professor Ikeda termed this flavor umami. He then patented a method of mass-producing a crystalline salt of glutamic acid, monosodium glutamate.
A differential mobility analyzer (DMA) makes use of a fast gas stream perpendicular to the electric field. Thereby ions of different mobilities undergo different trajectories. This type of IMS corresponds to the sector instruments in mass spectrometry. They also work as a scannable filter. Examples include the differential mobility detector first commercialized by Varian in the CP-4900 MicroGC. Aspiration IMS operates with open-loop circulation of sampled air. Sample flow is passed via ionization chamber and then enters to measurement area where the ions are deflected into one or more measuring electrodes by perpendicular electric field which can be either static or varying. The output of the sensor is characteristic of the ion mobility distribution and can be used for detection and identification purposes.
Sources: en.wikipedia.org
The standard approach is reverse-phase high-performance liquid chromatography, reported as a percentage of total peak area. Because that figure alone says little about the nature of the impurities, the accompanying chromatogram is normally the more useful document for judging a batch.
Cold storage at minus twenty degrees Celsius or below is the common recommendation for the lyophilized powder, together with protection from light and moisture. Dissolved material is generally treated as less stable and is handled cold with short working windows.
A useful certificate lists the analytical method used, the measured purity, the mass determined by spectrometry, and the storage conditions. Independent verification from a second laboratory is sometimes requested, since supplier-issued documents are not always produced in the same facility as the material.
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.